🚫🧪 Triton X-100 is now banned in the EU—but still ingrained in many lab workflows. See how CST scientists validated a greener, high‑performing alternative without sacrificing staining quality or reproducibility.
♻️ Read the full story on the #CSTBlog.
hubs.ly/Q04d488P0
54
🧶🧬 Why are epigenetic changes such powerful cancer “switches”—and how can some be reversed?
👉 Learn how nonmutational epigenetic reprogramming fuels EMT and cell survival, and explore key biomarkers, pathway diagrams, and antibody tools on the #CSTBlog
hubs.ly/Q04g8ddn0
52
🏗️🩸How is tumor vasculature influenced by immune cells and the stroma in the TME?
👉 Learn about how tumor-associated macrophages, neutrophils, and stromal cells help promote angiogenesis—and the antibody tools to track them—on the #CSTBlog.
hubs.ly/Q04g7R3x0
59
Frog, fly, yeast, zebrafish 🐸🪰🍞🐟…Different model, same PTMScan® reagents.
Our PTMScan antibodies pull down phospho‑, acetyl‑, ubiquitin‑modified, and other PTM peptides, regardless of species. Learn more on the #CSTBlog.
hubs.ly/Q04fGqL10
54
In #TargetedProteinDegradation, western blots and ubiquitination assays can only take you so far. In our latest #CSTBlog, learn how pairing those assays with DIA #proteomics and ubiquitin remnant enrichment helps you:
🎯 Distinguish true substrates from indirect effects
1
85
Too many markers and not sure where to start? 🌈🔬
Our latest #CSTblog breaks down when to use direct vs indirect multiplex IF, plus beginner‑friendly protocols so you can get your first 3–4‑color panel up and running.
hubs.ly/Q046nHff0
76
What does it take to swap a lab workhorse like Triton X-100 for a greener alternative, without compromising scientific integrity? 📊♻️
Learn how CST scientists validated an eco-friendly surfactant for use in our labs on the #CSTBlog.
hubs.ly/Q04d4b9J0
2
79
Selecting antibodies for multiplex spatial biology? Don’t forget the antibody compatibility trifecta: platform, workflow, and tissue type.
🎯 Learn how to choose CST antibodies that fit your multiplex platform and tissue preparation on the #CSTblog.
hubs.ly/Q045zG320
93
Accelerate your CAR-T studies with protein-level insights from your single cell CAR-T analyses. Learn how on the #CSTBlog👇
hubs.ly/Q041Qx-60
85
🧬🧶 How do tumors rewrite gene expression without changing the DNA sequence?
👉 Explore key DNA methylation and histone modification targets plus CST antibodies and chromatin profiling kits on the #CSTBlog.
hubs.ly/Q03-3hGl0
124
Profiling CAR-T cells? RNA data only tells part of the story.
Learn how to get direct, protein-level insights from your single-cell analyses, so you can distinguish which cells truly express your CAR construct. Learn more on the #CSTBlog
hubs.ly/Q041Q9z40
73
Even hot immunogenic tumors evade the immune system. Explore the top markers reshaping tumor-immune cell interaction research so you can look beyond PD‑1/PD‑L1.
🔗 Explore this Hallmark of Cancer on the #CSTBlog.
hubs.ly/Q03-1ltv0
81
10 Dec 2025
🧫✨3D cell culture models are rapidly moving from “nice-to-have” to “must-have” for translational drug discovery, especially as regulators endorse human-relevant NAMs over animal testing. Read the #CSTblog to see considerations for antibody selection ...
hubs.ly/Q03XGhCP0
80
20 Nov 2025
Visualize more targets in less time—learn how to profile neurons, astrocytes & microglia in one multiplex IF panel using CST chimeric antibodies. Get tips to speed your spatial biology research in the latest #CSTblog.
hubs.ly/Q03Vd6530
72
12 Nov 2025
🗣 Give me ANYTHING but rabbit! You asked, we listened.
Our new recombinant monoclonal portfolio has the neuronal and glial cell antibodies you trust, now in mouse, horse, and feline hosts.
Learn how to plex with confidence on the #CSTblog 👇
hubs.ly/Q03LKYlM0
1
1
170
1 Nov 2025
~60% of our antibodies are shipped at room temperature, eliminating the need for cold chain shipping and significantly reducing greenhouse gas emissions
Learn more about our ambient shipping practices and how we guarantee product stability on the #CSTBlog hubs.ly/Q03Ck1y-0
70
31 Oct 2025
🔬📚 The proof is in the publishing: For nine consecutive years, CST antibodies have led @CiteAb's Top 100.
Our rigorous validation means better antibodies, and better antibodies mean better science. Read the full story on the #CSTblog.
hubs.ly/Q03R5Vsf0
1
91
10 Oct 2025
Put the brakes on variability—standardize CAR expression in your flow cytometry experiments using Posibeads™ positive control beads from CST.
Learn how Posibeads control beads enable accurate data comparison across multiple experiments on the #CSTblog.
hubs.ly/Q03zkYFj0
91
24 Sep 2025
Studying CNS injury or astrocyte activation? Our latest #CSTblog covers key astrocyte and glial markers and strategies for using multiplex IF for astrogliosis research.
hubs.ly/Q03KPP9W0
67
20 Aug 2025
Avoid CAR Trouble with Posibeads™ positive control beads. 🏎️✨
Not sure if low #flowcytometry signal is due to poor immunostaining or a lack of CAR expression? Learn how to take the guesswork out of your data interpretation in this #CSTblog.
hubs.ly/Q03zkXJp0
98